Table 1.
Cup to disc ratio | Central corneal thickness | Maximum IOP | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Individual no. | Age at diagnosis or exam | Diagnosis | OD | OS | OD | OS | OD | OS | Visual field | Surgery |
93001 | 48 | POAG | 0.9 | 0.9 | 0.552 | NA | 26 | 46 | Severe loss OU | Trabeculectomy OU |
94099 | 58 | POAG | 0.7 | 0.4 | 0.578 | 0.568 | 21 | 28 | Superior loss OD | Trabeculectomy OU |
93005 | 38 | POAG | 0.7 | 0.7 | 0.544 | 0.550 | 28 | 24 | Nasal step OS | None |
93010 | 68 | POAG | 0.9 | 0.9 | 0.527 | 0.517 | 24 | 25 | Superior loss OD | None |
93012 | 57 | POAG | 0.7 | 0.6 | 0.572 | 0.592 | 22 | 23 | Nasal step OU | None |
93016 | 50 | POAG | 0.9 | 0.9 | NA | NA | 22 | 22 | NA | Laser trabeculoplasty OU |
94004 | 60 | POAG | 0.7 | 0.6 | NA | NA | 26 | 24 | NA | None |
94010 | 47 | POAG | 0.7 | 0.8 | 0.608 | 0.580 | 24 | 24 | Nasal step OS | None |
94024 | 55 | POAG | 0.5 | 0.7 | 0.599 | 0.594 | 21 | 25 | Nasal step OS | None |
94025 | 80 | POAG | 0.5 | 0.9 | NA | NA | 35 | 36 | NA | Laser trabeculoplasty OS |
02004a | 55 | POAG | 0.9 | 0.9 | NA | NA | 35 | 26 | Severe loss OU | Trabeculectomy OU |
04025 | 24 | Suspect | 0.3 | 0.3 | 0.590 | 0.590 | 32 | 25 | NA | None |
93011 | 58 | Suspect | 0.4 | 0.4 | 0.604 | 0.593 | 23 | 23 | Normal | None |
94075 | 32 | Suspect | 0.5 | 0.5 | 0.532 | 0.544 | 18 | 17 | NA | None |
94023 | 66 | Suspect | 0.5 | 0.5 | 0.532 | 0.533 | 18 | 18 | NA | None |
94013 | 39 | Suspect | 0.4 | 0.4 | 0.566 | 0.572 | 20 | 20 | NA | None |
94002 | 56 | Normal | 0.3 | 0.3 | 0.543 | 0.547 | 19 | 18 | NA | None |
94019 | 16 | Normal | 0.3 | 0.3 | 0.552 | 0.543 | 16 | 16 | NA | None |
05040 | 19 | Normal | 0.2 | 0.2 | 0.544 | 0.554 | 20 | 20 | NA | None |
05041 | 17 | Normal | 0.2 | 0.2 | 0.551 | 0.540 | 20 | 20 | NA | None |
93013 | 74 | Normal | 0.3 | 0.3 | 0.626 | 0.650 | 17 | 18 | NA | None |
No DNA is available; the genotype of this individual is inferred from her daughter and granddaughter's status.
IL-20R, interleukin-20 receptor; POAG, primary open angle glaucoma; IOP, intraocular pressure; OD, oculus dexter; OS, oculus sinister; OU, oculus uterque.